Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capstone Pharmaceuticals is a specialty pharmaceutical and medical device company focused on the commercialization of innovative products in the United States market. Based in Memphis, Tennessee, the company operates as a division of Capstone Healthcare and specializes in therapeutic areas such as wound care, podiatry, urology, and pain management. Its product portfolio includes advanced wound care solutions like KeraStat and KeraGel, as well as the Bionect line of hyaluronic acid-based treatments. Capstone leverages strategic partnerships with global manufacturers to bring high-quality, clinically proven therapies to healthcare providers and patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capstone Pharmaceuticals.